Clinical Trials Directory

Trials / Completed

CompletedNCT03388086

Efficacy of Two Onabotulinum Toxin Doses

Comparing the Efficacy of Two Doses of Onabotulinum Toxin for the Treatment of Neurogenic Detrusor Overactivity - a Retrospective Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
56 (actual)
Sponsor
Swiss Paraplegic Research, Nottwil · Network
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The changes in bladder function after the injection of Onabotulinum toxin into the detrusor in individuals with neurogenic bladder overactivity will be investigated retrospectively. The records of all patients treated with Onabotulinum toxin injections into the detrusor since 2000 will be evaluated. The changes in the urodynamic values after the injection of 300 units of Onabotulinum toxin will be compared with the changes after the injection of 200 units. Furthermore, the differences in urinary continence, duration between injections, side effects and complications between the two groups will be investigated.

Conditions

Interventions

TypeNameDescription
DRUGInjection of Onabotulinum toxinmultiple injections of Onabotulinum toxin into the detrusor muscle

Timeline

Start date
2018-02-01
Primary completion
2019-04-30
Completion
2019-07-31
First posted
2018-01-02
Last updated
2019-08-06

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03388086. Inclusion in this directory is not an endorsement.